Related Experiment Video
Updated: May 7, 2025
06:21
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
1.3K
Invasive Hemodynamic Changes Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Systematic Review and
Abiodun Idowu1, Olayinka Adebolu1, Casipit Bruce1
1Department of Medicine Einstein Medical Center, Philadelphia, Pennsylvania, USA.
Cardiovascular Therapeutics
|January 1, 2025
Summary
Sodium-glucose cotransporter-2 inhibitors (SGLT2is) improve heart failure outcomes by reducing pulmonary capillary wedge pressure. These findings offer mechanistic insights into SGLT2i benefits for heart failure patients.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Sodium-glucose cotransporter-2 inhibitors (SGLT2is) demonstrate efficacy in reducing heart failure (HF) incidence and hospitalizations.
- The precise hemodynamic mechanisms underlying SGLT2i's cardiovascular benefits remain incompletely understood.
Approach:
- A systematic review and meta-analysis were conducted following PRISMA guidelines.
- Included randomized trials evaluated the impact of SGLT2 inhibitors on invasive hemodynamics measured by right heart catheterization.
- Data from 3 studies involving 145 patients were analyzed using a random-effects model.
Key Points:
- SGLT2 inhibitors significantly reduced pulmonary capillary wedge pressure at rest and during peak exercise.
- A trend towards reduction in mean pulmonary artery pressure was observed, though not statistically significant.
- Hemodynamic improvements suggest a potential mechanism for SGLT2i's positive effects on heart failure.
Conclusions:
- SGLT2 inhibitors exert beneficial effects on central hemodynamics in patients.
- These hemodynamic changes provide mechanistic insights into why SGLT2 inhibitors improve heart failure outcomes.
- Further research is warranted to fully elucidate the role of SGLT2i in cardiovascular disease management.
Related Concept Videos
01:16Antihypertensive Drugs: Action of Diuretics
566
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
566
01:26Heart Failure Drugs: Inotropic Agents
395
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
395
01:27Glucose Transporters
22.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.2K
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
394
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
394
01:55Secondary Active Transport
116.7K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
116.7K
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.0K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.0K